text block


November 6, 2012 | News

ASAHI INTECC CO., LTD. announces the launch of ASAHI CHIKAI and ASAHI CHIKAI 10 Neurovascular Guide Wires in the US and Europe

ASAHI INTECC CO., LTD., a leading developer and manufacturer of interventional guide wires and catheters, has announced the launch of ASAHI CHIKAI and ASAHI CHIKAI 10 neurovascular guide wires in the US and Europe and will begin promotion at LINC (Live Interventional Neuroradiology Conference) on December from 11th to 13th in Houston, TX. ASAHI INTECC USA, INC., our subsidiary and ASAHI INTECC CO., LTD EUROPE will sell the guide wires via a direct sales team in the US and local distributors in Europe.
ASAHI INTECC CO., LTD.’s unique technologies in wire drawing, wire forming, torque transmission and coating are utilized to create highly responsive guide wires featuring ASAHI’s ACTONE, dual-coil design. ASAHI CHIKAI and ASAHI CHIKAI 10 were developed as workhorse guide wires to treat intracranial aneurysms, cerebral arteriovenous fistulas and cerebral arteriovenous malformations and provide the exceptional torque response, tip flexibility and device deliverability required for these treatments.
ASAHI CHIAKI and ASAHI CHIKAI 10 were launched in Japan in January, 2010 and have been well accepted by Japanese physicians and achieved more than 40% market share as of June, 2012.
Nobuyuki Sakai, MD, Director, Neurosurgery and Stroke Center at Kobe City Medical Center General Hospital said, “ASAHI CHIKAI guide wire’s precise torque provides exceptional control never before seen in the neuro interventional procedures.”
Toshio Hyogo, MD, Director, R&D Clinical Applications, Neuro Products at ASAHI INTECC CO., LTD., commented, “We designed ASAHI CHIKAI guide wire to have optimal performance characteristics for neuro interventional procedures with a balance between distal flexibility, precise torqueability and support for microcatheter delivery. We are very proud of the performance achieved by leveraging ASAHI’s unique technologies of torque transmission and shape retention.”
Mr. Masahiko Miyata, President and CEO added, “ASAHI CHIKAI and ASAHI CHIKAI 10 have been successful due to the collaboration between Japanese key opinion leaders and ASAHI INTECC’s technologies. I am confident that these guide wires will be well accepted internationally and contribute to improving patient’s quality of life worldwide.”


ASAHI INTECC CO., LTD. manufactures medical devices, industrial materials and innovative products with a unique and unprecedented wire processing technology. ASAHI’ operations are spread across the US, Europe, Singapore, China and Hong Kong and are headquartered in Seto, Japan.